New York: U.S. stocks are wobbling between small gains and losses while hovering around their recent record highs as coronavirus vaccines move closer to distribution and Washington ramps up stimulus talks.A vaccine from Pfizer and German partner BioNTech, which is already in use in the U.K., is on track for a positive review and potential approval in the U.S.
within the next week. The Food and Drug Administration will also consider a vaccine developed by Moderna later this month. The prospect for a vaccine is giving Wall Street hope that the economy is nearing a more direct path to a full recovery.The S&P 500 slipped 0.2% in late morning trading Wednesday, putting it just below its record of 3,702.25 set on Tuesday.